Diagnostic value of peripheral blood inflammatory indices for breast cancer grade and immunohistochemical markers: a retrospective observational study
Nahid Nafissi, Mohammad Rezazadeh, Ahmadreza Kheradpishe, Hanieh Radkhah, Maedeh Bayani, Bahareh Shateri Amiri, Ghazal Tavakoli, Mohammad Mehdi Hasheminezhad, Maryam Khalili, Asma Mousavi · 2025
Read Diagnostic value of peripheral blood inflammatory indices for breast cancer grade and immunohistochemical markers: a retrospective observational study by Nahid Nafissi, Mohammad Rezazadeh, Ahmadreza Kheradpishe, Hanieh Radkhah, Maedeh Bayani, Bahareh Shateri Amiri, Ghazal Tavakoli, Mohammad Mehdi Hasheminezhad, Maryam Khalili, Asma Mousavi (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12746618.txt.
Description
Nahid Nafissi and co-authors test cheap blood ratios as clues to breast tumor character in a 2025 study. Inflammation leaves fingerprints in routine blood counts, and six combined indices built from them might track how aggressive a tumor is. The study covered 114 patients at one Tehran hospital who had breast tumors removed between 2020 and 2024. Biopsy results gave each tumor's grade and its hormone and HER2 marker status.
Statistical models asked whether the blood indices, computed before surgery, lined up with those tumor traits. A blood test that hints at grade could help planning where advanced pathology is scarce. The indices cost nothing beyond a standard blood draw, which is the whole appeal.
Catalog record
| CREATOR | Nahid Nafissi, Mohammad Rezazadeh, Ahmadreza Kheradpishe, Hanieh Radkhah, Maedeh Bayani, Bahareh Shateri Amiri, Ghazal Tavakoli, Mohammad Mehdi Hasheminezhad, Maryam Khalili, Asma Mousavi |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 40 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |